In April 2025, a decision was made to suspend the national medicines repurposing programme.

The decision was made with consideration to the following factors:

1. The programme team and partners have learned that there are fewer repurposing opportunities in practice than was originally envisaged when the programme was established. Partly this is because many opportunities to use existing medicines in new ways can be delivered without a formal repurposing programme.
2. Very few repurposed medicines have a strong enough evidence base to support a licence variation.
3. The planned integration of NHS England into the Department of Health and Social Care.

Any further update(s) will be communicated in due course.